The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
A Hyaluronic Acid−Taxol Antitumor Bioconjugate Targeted to Cancer Cells
Abstract
A cell-targeted polymeric prodrug prepared from Taxol and chemically modified hyaluronic acid (HA) was evaluated in vitro. Herein we report four results in support of the selective uptake and targeted toxicity of the HA-Taxol prodrug. First, a fluorescently labeled HA-Taxol (FITC-HA-Taxol) was synthesized and used to demonstrate cell-specific binding and uptake using flow cytometry and confocal microscopy. Second, the selective cytotoxicity of FITC-HA-Taxol allowed direct correlation of uptake with selective cytotoxicity. Third, the rapid uptake and selective cytotoxicity of HA-Taxol bioconjugates could be blocked by either excess HA or by an anti-CD44 antibody, but not by chondroitin sulfate (CS). Finally, the release of free Taxol from HA-Taxol in human plasma or in cell culture media revealed that the free drug was hydrolytically released from the bioconjugate by cleavage of the labile 2' ester linkage. Taken together, these data support the notion that the targeted cytotoxicity of HA-Taxol bioconjugates requires receptor-mediated cellular uptake of the bioconjugate followed by hydrolytic release of free Taxol.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyaluronan‐binding proteins in development, tissue homeostasis, and disease
Knudson, C. B., & Knudson, W. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.13.7691670 · Cited by 649
Underhill, C. (1992) · Journal of Cell Science · doi:10.1242/jcs.103.2.293 · Cited by 609
Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo
Maeda, H., Seymour, L. W., & Miyamoto, Y. (1992) · Bioconjugate Chemistry · doi:10.1021/bc00017a001 · Cited by 560
HA receptors: Regulators of signalling to the cytoskeleton
Entwistle, J., Hall, C. L., & Turley, E. A. (1996) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19960616)61:4<569::aid-jcb10>3.0.co;2-b · Cited by 472
The chemistry, biology and medical applications of hyaluronan and its derivatives
Balazs, E. A., & Laurent, T. C. (1998) · Portland eBooks · Cited by 447
The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan.
Culty, M., Nguyen, H. A., & Underhill, C. B. (1992) · The Journal of cell biology · doi:10.1083/jcb.116.4.1055 · Cited by 395
Hyaluronidases - a group of neglected enzymes
Kreil, G. (1995) · Protein Science · doi:10.1002/pro.5560040902 · Cited by 343
Toole, B. P. (1997) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1997.00171.x · Cited by 320
Laurent, T. C., Laurent, U. B., & Fraser, J. R. (1995) · Annals of the Rheumatic Diseases · doi:10.1136/ard.54.5.429 · Cited by 305
The role of hyaluronan in tumour neovascularization (review)
Rooney, P., Kumar, S., Ponting, J., & Wang, M. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600511 · Cited by 271
Cited by
Main properties and current applications of some polysaccharides as biomaterials
Rinaudo, M. (2008) · Polymer International · doi:10.1002/pi.2378 · Cited by 1,028
Misra, S., Hascall, V. C., Markwald, R. R., & Ghatak, S. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00201 · Cited by 830
Schanté, C. E., Zuber, G., Herlin, C., & Vandamme, T. F. (2011) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2011.03.019 · Cited by 708
The magic glue hyaluronan and its eraser hyaluronidase: A biological overview
Girish, K. S., & Kemparaju, K. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.02.037 · Cited by 674
Sulfated Seaweed Polysaccharides as Multifunctional Materials in Drug Delivery Applications
Cunha, L., & Grenha, A. (2016) · Marine Drugs · doi:10.3390/md14030042 · Cited by 611
Glycosaminoglycans: key players in cancer cell biology and treatment
Afratis, N., Gialeli, C., Nikitovic, D., Tsegenidis, T., Karousou, E., Theocharis, A. D., Pavão, M. S., Tzanakakis, G. N., & Karamanos, N. K. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08529.x · Cited by 554
Oh, E. J., Park, K., Kim, K. S., Kim, J., Yang, J.-A., Kong, J.-H., Lee, M. Y., Hoffman, A. S., & Hahn, S. K. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.09.010 · Cited by 540
Hyaluronan–CD44 interactions as potential targets for cancer therapy
Misra, S., Heldin, P., Hascall, V. C., Karamanos, N. K., Skandalis, S. S., Markwald, R. R., & Ghatak, S. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08071.x · Cited by 494
Recent advances in tumor-targeting anticancer drug conjugates
Jaracz, S., Chen, J., Kuznetsova, L. V., & Ojima, I. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.04.084 · Cited by 490
Platt, V. M., & Szoka, F. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800024g · Cited by 456
Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin
Brown, M., & Jones, S. (2005) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2004.01180.x · Cited by 373
Proteoglycan Chemical Diversity Drives Multifunctional Cell Regulation and Therapeutics
Karamanos, N. K., Piperigkou, Z., Theocharis, A. D., Watanabe, H., Franchi, M., Baud, S., Brézillon, S., Götte, M., Passi, A., Vigetti, D., et al. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00354 · Cited by 367
Hyaluronic Acid and Controlled Release: A Review
Bayer, I. S. (2020) · Molecules · doi:10.3390/molecules25112649 · Cited by 356
Hyaluronan: Pharmaceutical Characterization and Drug Delivery
Liao, Y.-H., Jones, S. A., Forbes, B., Martin, G. P., & Brown, M. B. (2005) · Drug Delivery · doi:10.1080/10717540590952555 · Cited by 342
Hyaluronan and synovial joint: function, distribution and healing
Tamer, T. M. (2013) · Interdisciplinary Toxicology · doi:10.2478/intox-2013-0019 · Cited by 317
Influence of the degree of methacrylation on hyaluronic acid hydrogels properties
Bencherif, S. A., Srinivasan, A., Horkay, F., Hollinger, J. O., Matyjaszewski, K., & Washburn, N. R. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.11.047 · Cited by 313
The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer
Thapa, R., & Wilson, G. D. (2016) · Stem Cells International · doi:10.1155/2016/2087204 · Cited by 312
Prodrug-based intracellular delivery of anticancer agents
Bildstein, L., Dubernet, C., & Couvreur, P. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.12.005 · Cited by 310
Emerging roles of hyaluronic acid bioscaffolds in tissue engineering and regenerative medicine
Hemshekhar, M., Thushara, R. M., Chandranayaka, S., Sherman, L. S., Kemparaju, K., & Girish, K. S. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.02.032 · Cited by 283
Cai, S., Vijayan, K., Cheng, D., Lima, E. M., & Discher, D. E. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9335-z · Cited by 274
Modified hyaluronic acid based materials for biomedical applications
Tiwari, S., & Bahadur, P. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.10.049 · Cited by 269
Hyaluronic Acid Bioconjugates for the Delivery of Bioactive Molecules
Mero, A., & Campisi, M. (2014) · Polymers · doi:10.3390/polym6020346 · Cited by 264
Yao, J., Zhang, L., Zhou, J., Liu, H., & Zhang, Q. (2013) · Molecular Pharmaceutics · doi:10.1021/mp3005808 · Cited by 87
Tirella, A., Kloc-Muniak, K., Good, L., Ridden, J., Ashford, M., Puri, S., & Tirelli, N. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.02.032 · Cited by 60
Trends in biopolymer science applied to cosmetics
Mendoza‐Muñoz, N., Leyva‐Gómez, G., Piñón‐Segundo, E., Zambrano‐Zaragoza, M. L., Quintanar‐Guerrero, D., Del Prado Audelo, M. L., & Urbán‐Morlán, Z. (2023) · International Journal of Cosmetic Science · doi:10.1111/ics.12880 · Cited by 42
Metadata
- Authors
- Luo, Y., Ziebell, M. R., & Prestwich, G. D.
- Venue
- Biomacromolecules
- Publisher
- American Chemical Society (ACS)
- Published
- 2000-03-25
- Volume
- 1
- Issue
- 2
- Pages
- 208-218
- ISSN
- 1525-7797 (ISSN-L)
- 1526-4602
- OpenAlex
- W1978235057
- Cited by
- 261
- References
- 31
- FWCI
- 2.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.